Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency | Zendy

Thomas Zeller | Zendy; Ralf Langhoff | Zendy; Krishna J. RochaSingh | Zendy; Michael R. Jaff | Zendy; Erwin Blessing | Zendy; Beatrice AmannVesti | Zendy; Marek Krzanowski | Zendy; Patrick Peeters | Zendy; Dierk Scheinert | Zendy; Giovanni Torsello | Zendy; Sebastian Sixt | Zendy; Gunnar Tepe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency

Author(s) -

Thomas Zeller,

Ralf Langhoff,

Krishna J. RochaSingh,

Michael R. Jaff,

Erwin Blessing,

Beatrice AmannVesti,

Marek Krzanowski,

Patrick Peeters,

Dierk Scheinert,

Giovanni Torsello,

Sebastian Sixt,

Gunnar Tepe

Publication year - 2017

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.116.004848

Subject(s) - restenosis , medicine , atherectomy , balloon , paclitaxel , lesion , stenosis , radiology , angioplasty , target lesion , claudication , surgery , stent , arterial disease , vascular disease , chemotherapy , percutaneous coronary intervention , myocardial infarction

Studies assessing drug-coated balloons (DCB) for the treatment of femoropopliteal artery disease are encouraging. However, challenging lesions, such as severely calcified, remain difficult to treat with DCB alone. Vessel preparation with directional atherectomy (DA) potentially improves outcomes of DCB.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research